Chemoinformaics analysis of BETA-N-OXALO-L-ALPHA-BETA-DIAMINOPROPIONIC-ACID
Molecular Weight | 176.128 | nRot | 3 |
Heavy Atom Molecular Weight | 168.064 | nRig | 3 |
Exact Molecular Weight | 176.043 | nRing | 0 |
Solubility: LogS | -1.248 | nHRing | 0 |
Solubility: LogP | -3.59 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 19.8943 |
nHD | 4 | BPOL | 10.6297 |
QED | 0.354 |
Synth | 2.746 |
Natural Product Likeliness | 0.666 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.475 |
HIA | 0.016 |
CACO-2 | -6.477 |
MDCK | 0.00336188 |
BBB | 0.221 |
PPB | 0.0968753 |
VDSS | 0.332 |
FU | 0.813305 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.01 |
CYP2c19-inh | 0.09 |
CYP2c19-sub | 0.033 |
CYP2c9-inh | 0.174 |
CYP2c9-sub | 0.217 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.131 |
CYP3a4-inh | 0.015 |
CYP3a4-sub | 0.003 |
CL | 3.561 |
T12 | 0.721 |
hERG | 0.021 |
Ames | 0.036 |
ROA | 0.007 |
SkinSen | 0.218 |
Carcinogencity | 0.014 |
EI | 0.112 |
Respiratory | 0.13 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.866295 |